Potential angiogenic biomarkers in hereditary hemorrhagic telangiectasia and other vascular diseases
Author:
Publisher
Elsevier BV
Subject
Internal Medicine
Reference99 articles.
1. Novel biomarkers of cardiovascular disease: applications in clinical practice;Lyngbakken;Crit Rev Clin Lab Sci,2019
2. Graupera M, Viñals F. Translational medicine in hereditary hemorrhagic telangiectasia;Riera-Mestre;Eur J Intern Med,2022
3. Biomarkers of cardiovascular disease: molecular basis and practical considerations;Vasan;Circulation,2006
4. The portal for rare diseases and orphan drugs. Available online: https://www.orpha.net/consor/cgi-bin/index.php (Accessed on Jul 4, 2020).
5. Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia;Faughnan;Ann Intern Med,2020
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Molecular and Functional Cargo of Plasma-Derived Exosomes in Patients with Hereditary Hemorrhagic Telangiectasia;Journal of Clinical Medicine;2024-09-13
2. Molecular mechanisms and clinical manifestations of hereditary hemorrhagic telangiectasia;Thrombosis Research;2024-09
3. The arduous challenge of seeking for biomarkers in rare diseases;European Journal of Internal Medicine;2023-09
4. Aflibercept for Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia: A Case Report;Medicina;2023-08-24
5. Update August 2023;Lymphatic Research and Biology;2023-08-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3